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Abstract: Objective: The aim of this study was to investigate sex differences in the burden of migraine
and tension-type headache (TTH). Background: Migraine and TTH are more common in women
than in men, with differences in comorbidities, treatment responses, disease-modifying factors, and
ictal and interictal burden of disease. Information about sex-related influences on ictal and interictal
burden is limited, and an increased understanding is mandatory to provide tailored individual
treatment for female and male patients. Methods: Participants answered an online survey based on
the EUROLIGHT questionnaire. Inclusion criteria were the consent to participate, complete responses
to the diagnostic questions, and information about their sex. Sex differences were investigated using
the Mann–Whitney U test or Chi-square test. For detecting factors that influence the burden of
disease, we built binary regression models. Results: We included 472 (74.6% female) migraineurs
and 161 (59.6% female) participants with TTH. Women with migraine reported significantly more
problems in their love lives, more self-concealment, less feelings of being understood by family and
friends, more interictal anxiety, a higher pain severity, and more depression and anxiety symptoms
than men. For TTH, we did not find significant sex-related differences. A higher headache frequency
was the factor that increased the burden of disease in female but not in male migraneurs. Conclusion:
The burden of disease was higher in women than men with migraine in many aspects, but not
with TTH. Therefore, according to our results, there is a need for sex-specific precision medicine
for migraine but not TTH. Controlling the headache frequency with a proper acute or prophylactic
treatment and treating comorbid depression and anxiety symptoms is crucial to ease migraine’s
burden, especially in women.
Keywords: sex differences; burden of disease; migraine; tension-type headache; precision medicine
1. Introduction
Primary headache disorders affect 46% of the general adult population; 11% suffer
from migraine and 42% from tension-type headache (TTH) [1]. Both headache types are
three times more common in women than in men [2,3].
These sex-related differences do not only regard epidemiology but also comorbidi-
ties [4,5], treatment responses [6], and disease-modifying factors [7,8]. Previous studies
documented differences between women and men in attack frequency, duration and pain
intensity. Furthermore, anxiety and depression symptoms differ for both migraine and
TTH [5,9–13]. They suggest itself that these factors, together with the interaction with the
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healthcare system, influence a person´s disease burden. However, there is also evidence
that females’ and males’ reactions to their social environments differ in illnesses [14].
Therefore, we hypothesized that factors influencing the burden of headache might
differ between the sexes in many more aspects than those presently known. However,
knowledge is scarce as no study compared sex-related influences on the ictal and interictal
burden of migraine and TTH.
Recent years have witnessed a growing demand for precision medicine of which,
according to Mauvais-Jarvis and co-workers, sex and gender are the foundation [15].
They concluded that sex (as a biological construct) was a genetic modifier of disease
pathophysiology, clinical presentation, and treatment response. At the same time, gender
(as a social construct) influenced the behavior of and towards patients, thereby modifying
and determining their access to medical care.
This study investigates sex-related differences in the burden of migraine and TTH
and analyzes sex-specific aspects, which influences this burden. Finally, we hope that our
results will increase the understanding of sex-related differences and contribute to more
individual and precise treatments.
2. Materials and Methods
2.1. Study Design, Inclusion and Exclusion Criteria
The study was internet-based and cross-sectional. Having been informed through
posters, journal articles and web pages, participants enrolled from March 2019 to March
2020 and completed the EUROLIGHT questionnaire [16].
We included those who consented to participate and excluded those who provided
incomplete responses to the diagnostic questions or did not disclose their biological sex.
As participation was anonymous, the study did not require further ethical approval
according to Swiss legislation.
2.2. Outcome Measures
A previously published diagnostic algorithm allowed diagnosing probable migraine,
migraine, probable TTH, and TTH [16]. These questions comprised one item that asked
participants to rate their pain intensity on an ordinal scale (“not bad”, “bad”, or “very bad”).
Furthermore, the participants answered questions about the ictal and interictal burden
with dichotomous answers (yes/no); see Table 1. Three questions assessed interaction
with the direct social environment, two questions assessed fear of pain and avoidance
behavior, and six questions inquired about the interaction with the healthcare system
and diagnostics.
We estimated anxiety levels and the number of depressive symptoms with the self-
rated Hospital Anxiety and Depression scale (HADS), consisting of seven items indicating
anxiety (HADS-A) and seven items indicating depressive symptoms (HADS-D). Partici-
pants rated their accordance with each item on a 4-point Likert scale (0–3), with a higher
score indicating more severe symptoms and a maximum of 21 points for each subscale [17].
The threshold indicating possible anxiety and possible depression was eight; the threshold
indicating anxiety or depression was eleven [18].
In this work, we differentiated participants based on their biological sex as male and
female. We assumed a high overlap between gender and sex among our participants and
discussed potential biological and social influences on the burden of disease equally.
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Table 1. Disease burden of participants with migraine.
All Females (%) Males (%) Chi-Square p-Value
472 392 (83.1) 80 (16.9)
Problems in love life due to headache in the
past 3 months
No 267 (64.49) 211 (61.52) 56 (78.87) 7.739 0.005
Yes 147 (35.51) 132 (38.48) 15 (21.13)
58 n.r. 49 n.r. 9 n.r.
“Do you avoid telling people that you
have headaches?”
No 265 (61.34) 208 (58.26) 57 (76.00) 8.222 0.004
Yes 167 (38.66) 149 (41.74) 18 (24.00)
40 n.r. 35 n.r. 5 n.r.
“Do you feel that your family and friends
understand and accept your headaches?”
No 74 (17.13) 68 (18.99) 6 (8.11) 5.120 0.024
Yes 358 (82.87) 290 (81.01) 68 (91.89)
40 n.r. 34 n.r 6 n.r.
“On that day, was there anything you could
not do or did not do because you wanted to
avoid getting a headache?”
No 288 (70.24) 235 (68.51) 3 (79.10) 3.008 0.083
Yes 122 (29.76) 108 (31.49) 14 (20.90)
62 n.r. 49 n.r. 13 n.r.
“On that day, were you anxious or worried
about your next headache episode?”
No 288 (69.59) 232 (67.25) 56 (82.35) 6.142 0.013
Yes 125 (30.41) 113 (32.75) 12 (17.65)
59 n.r. 47 n.r. 12 n.r.
Headache specialist: “Have you had
professional advice about your headache in
the last year?”
No 171 (61.29) 152 (61.63) 19 (57.58) 0.218 0.641
Yes 108 (38.71) 94 (38.37) 14 (42.42)
193 n.r 146 n.r. 47 n.r
Primary care doctor: “Have you had
professional advice about your headaches in
the last year?”
No 145 (51.97) 131 (53.47) 14 (60.87) 1.367 0.242
Yes 134 (48.03) 115 (46.53) 19 (39.13)
193 n.r. 146. n.r. 47 n.r.
“Has a doctor ever given you a diagnosis for
this headache?”
No 183 (38.94) 140 (35.81) 43 (54.53) 9.588 0.002
Yes 287 (61.06) 251 (64.19) 36 (45.57)
2 n.r. 1 n.r 1 n.r.
“Because of your headaches, have you had
an MRI scan in the last year?”
Yes 76 (39.18) 69 (39.88) 7 (33.33) 0.337 0.561
No 118 (60.82) 104 (60.12) 14 (66.67)
278 n.r. 119 n.r. 59 n.r.
“Because of your headaches, have you had a
CT scan in the last year?”
Yes 32 (16.49) 26 (15.03) 6 (28.57) 2.493 0.114
No 162 (83.51) 147 (84.97) 15 (71.43)
278 n.r. 119 n.r. 59 n.r.
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Table 1. Cont.
All Females (%) Males (%) Chi-Square p-Value
“Because of your headaches, have you had X
rays of the neck in the last year?”
Yes 21 (10.82) 19 (10.98) 2 (9.52) 0.041 0.839
No 173 (89.18) 154 (89.02) 19 (90.48)
278 n.r. 119 n.r. 59 n.r.
“How bad is this headache usually?”
Not Bad 27 (5.72) 16 (4.08) 11 (13.75) 16.306 <0.001
Bad 261 (55.30) 212 (54.08) 49 (61.25)
Very Bad 184 (38.98) 164 (41.84) 20 (25.00)
0 n.r 0 n.r. 0 n.r.
all females males





7.11 (± 5.28) 7.37 (± 5.33) 5.85 (± 4.83) 11496.500 0.045
98 n.r. 82 n.r. 16 n.r.
HADS Anxiety
8.51 (± 4.61) 8.82 (± 4.63) 7.05 (± 4.42) 12291.50 0.004
99 n.r. 84 n.r. 15 n.r.
2.3. Statistical Analysis
We reported categorical variables as frequencies and means with standard deviations
and confidence intervals for interval scaled variables. To investigate the influence of
the variable “sex” on categorical variables, we used Chi-squared tests; Mann–Whitney
U tests analyzed its influence on numerically scaled variables. The burden of disease was
investigated for migraine and TTH separately.
Building binary regression models, we analyzed whether age, headache frequency,
headache intensity, and the HADS-A and HADS-D influenced the disease burden of
migraineurs. We performed these analyses separately in women and men.
We set the significance level at 0.05 and performed the statistical analysis using IBM
SPSS version 27.0.1.0. Missing values were indicated as “not reported” (n.r.).
3. Results
A total of 976 participants enrolled in the study, and 633 (46.9%) met the inclusion cri-
teria. We diagnosed migraine and probable migraine in 472 (74.6%) participants, of whom
392 (392/472, 83.1%) were female. One hundred sixty-one participants (161/633, 25.4%), in-
cluding 96 (96/161, 59.6%) women, met the diagnostic criteria for a tension-type headache
(TTH) or probable TTH. In the following, the terms migraine and probable migraine, as
well as TTH and probable TTH, were lumped together as migraine and TTH, respectively.
The migraineurs’ mean ages were 40 ± 13 years; female and male participants did
not differ significantly in age (39 ± 13 years vs. 41 ± 12 years, p = 0.130). Their average
headache duration was 9 ± 7 days (women vs. men, 8 ± 8 days vs. 9 ± 7 days, p = 0.380)
during the last months before completing the questionnaire. The majority of migraineurs
were employed, working or studying (424/471, 90%) and married or living with a partner
(305/471, 64.8%).
The mean age of participants with TTH was 39 ± 12 years. Women’s and men’s ages
were not statistically significant in their differences (37 ± 13 vs. 41 ± 11, p = 0.057). During
the last month, the average headache duration was 9 ± 7 days (women vs. men, 8 ± 8 days
vs. 5 ± 6 days, p= 0.059). The majority of migraineurs were employed, working or studying
(155/161; 96.3%) and married or living with a partner (114/159, 89.6%).
Table 1 specifies the male and female migraineurs’ answers to dichotomous questions.
Women reported more problems in their love lives, more self-concealment, and less accep-
tance by their social environment. They worried more about the next headache episode,
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had higher pain levels, and had more depression and anxiety symptoms than men. Apart
from women receiving a headache diagnosis more often, there was no difference in contact
with doctors or diagnostics compared to men.
Supplementary Table S1 compares the burden of disease of women and men with
TTH; there were no statistically significant sex-related differences.
Table 2 lists the results of the regression models for women suffering from migraine.
After correcting for age, headache frequency, attack intensity, anxiety, and depressive
symptoms, we found that the headache frequency, intensity, and anxiety symptoms greatly
influenced the analyzed aspects of disease burden.
Table 3 summarizes the results of the regression models for men diagnosed with
migraine. Compared with women, the investigated covariates had less of an impact on the
burden of disease for most questions. A higher headache intensity, and more depression
and anxiety symptoms influenced problems in their love lives, and a longer headache
duration was associated with worrying more about the next headache episode.
Table 2. Summary of the regression analysis determining the burden of migraine in women.
Number of
Included Cases
Covariates p-Value Odds Ratio * 95%CI
“During the last 3 months, have
your headaches caused difficulties
in your love life? “(Yes)
296 Age 0.272 1.011 0.991–1.032
Headache frequency <0.001 1.094 1.055–1.135
Headache intensity 0.141 1.407 0.893–2.218
HADS-A 0.058 1.087 0.997–1.185
96 n.r. HADS-D 0.291 0.961 0.894–1.034
“Do you avoid telling people that
you have headaches?” (Yes)
300 Age 0.177 1.013 0.994–1.033
Headache frequency <0.001 1.074 1.037–1.112
Headache intensity 0.785 0.942 0.612–1.450
HADS-A 0.179 1.058 0.974–1.149
92 n.r. HADS-D 0.739 0.988 0.921–1.060
“Do you feel that your family and
friends understand and accept your
headaches?” (Yes)
300 Age 0.219 0.986 0.964–1.008
Headache frequency 0.048 0.963 0.927–1.000
Headache intensity 0.984 0.995 0.592–1.672
HADS-A 0.943 0.996 0.903–1.100
92 n.r. HADS-D 0.332 0.959 0.882–1.043
“On that day, was there anything
you could not do or did not do
because you wanted to avoid
getting a headache?” (No)
295 Age 0.907 0.999 0.978–1.020
Headache frequency 0.010 0.954 0.920–0.988
Headache intensity 0.003 0.474 0.292–0.771
HADS-A 0.027 0.905 0.829–0.989
97 n.r. HADS-D 0.279 1.042 0.967–1.122
“On that day, were you anxious or
worried about your next
headache episode?” (No)
296 Age 0.360 1.010 0.989–1.031
Headache frequency <0.001 0.937 0.904–0.971
Headache intensity 0.004 0.495 0.305–0.803
HADS-A 0.025 0.905 0.829–0.987
96 n.r. HADS-D 0.932 1.003 0.933–1.079
Headache specialist: “Have you
had professional advice about your
headaches in the last year?” (Yes)
200 Age 0.941 1.001 0.978–1.024
Headache frequency 0.002 1.065 1.023–1.108
Headache intensity 0.492 1.209 0.704–2.077
HADS-A 0.337 0.952 0.862–1.052
192 n.r. HADS-D 0.981 1.001 0.921–1.088
Primary care doctor: “Have you
had professional advice about your
headaches in the last year?” (Yes)
200 Age 0.634 0.995 0.973–1.017
Headache frequency 0.002 1.064 1.022–1.108
Headache intensity 0.914 1.029 0.615- 1.722
HADS-A 0.110 1.082 0.982–1.193
192 n.r. HADS-D 0.321 0.960 0.887–1.040




Covariates p-Value Odds Ratio * 95%CI
“Has a doctor ever given you a
diagnosis for this headache?” (Yes)
300 Age 0.988 1.000 0.981–1.019
Headache frequency 0.023 1.044 1.006–1.083
Headache intensity 0.002 2.007 1.287–3.129
HADS-A 0.544 1.026 0.944–1.116
92 n.r. HADS-D 0.231 0.957 0.891–1.028
“Because of your headaches, have
you had an MRI scan in the
last year?” (Yes)
137 Age 0.030 0.967 0.938–0.997
Headache frequency 0.046 1.048 1.001–1.098
Headache intensity 0.174 1.588 0.815–3.093
HADS-A 0.933 0.995 0.880–1.125
255 n.r. HADS-D 0.507 0.966 0.874–1.069
“Because of your headaches, have
you had a CT scan in the
last year?” (Yes)
137 Age 0.808 0.995 0.958–1.034
Headache frequency 0.771 1.009 0.951–1.070
Headache intensity 0.352 0.669 0.287–1.559
HADS-A 0.178 1.117 0.951–1.312
255 n.r. HADS-D 0.127 0.898 0.783–1.031
“Because of your headaches, have
you had X rays of the neck in the
last year?” (Yes)
137 Age 0.506 1.017 0.968–1.068
Headache frequency 0.205 1.051 0.973–1.135
Headache intensity 0.664 1.281 0.419–3.915
HADS-A 0.041 1.248 1.009–1.542
255 n.r. HADS-D 0.767 1.024 0.873–1.202
* An odds ratio above one implies that higher age, headache frequency, headache intensity, scores in HADS-A or HADS-D increase the
likelihood of the answer given in brackets. An odds ratio smaller than 1 implies that younger age, lower headache frequency, scores in
HADS-A or HADS-D increase the likelihood of the answer given in brackets.
Table 3. Summary of the regression analysis determining the burden of migraine in men.
Number of
Included Cases
Covariates p-Value Odds Ratio * 95%CI
“During the last 3 months, have
your headaches caused difficulties
in your love life?” (Yes)
63 Age 0.972 0.999 0.940–1.062
Headache frequency 0.534 1.031 0.937–1.133
Headache intensity 0.042 3.521 1.047–11.844
HADS-A 0.024 0.712 0.530–0.956
7 n.r. HADS-D 0.028 1.353 1.034–1.771
“Do you avoid telling people that
you have headaches?” (Yes)
63 Age 0.695 0.989 0.934–1.046
Headache frequency 0.103 1.072 0.986–1.165
Headache intensity 0.841 1.117 0.378–3.301
HADS-A 0.401 0.895 0.690–1.160
7 n.r. HADS-D 0.094 1.227 0.966–1.558
“Do you feel that your family and
friends understand and accept your
headaches?” (Yes)
62 Age 0.916 1.005 0.924–1.092
Headache frequency 0.166 0.925 0.828–1.033
Headache intensity 0.369 0.487 0.101–2.344
HADS-A 0.623 1.096 0.762–1.567
8 n.r. HADS-D 0.447 0.885 0.645–1.213
“On that day, was there anything
you could not do or did not do
because you wanted to avoid
getting a headache?” (No)
60 Age 0.904 0.996 0.939–1.057
Headache frequency 0.545 1.030 0.935–1.136
Headache intensity 0.339 1.751 0.555–5.521
HADS-A 0.783 1.040 0.787–1.374
20 n.r. HADS-D 0.224 0.859 0.671–1.098
“On that day, were you anxious or
worried about your next
headache episode?” (No)
61 Age 0.688 0.986 0.922–1.055
Headache frequency 0.007 0.862 0.774–0.961
Headache intensity 0.442 0.594 0.157–2.242
HADS-A 0.332 0.872 0.661–1.150
19 n.r. HADS-D 0.125 1.253 0.939–1.671




Covariates p-Value Odds Ratio * 95%CI
Headache specialist: “Have you
had professional advice about your
headaches in the last year?” (Yes)
26 Age 0.850 1.008 0.931–1.090
Headache frequency 0.315 1.072 0.936–1.228
Headache intensity 0.805 1.194 0.292–4.877
HADS-A 0.997 0.999 0.715–1.397
54 n.r. HADS-D 0.889 1.022 0.751–1.391
Primary care doctor: “Have you
had professional advice about your
headaches in the last year?” (Yes)
26 Age 0.749 1.013 0.937–1.094
Headache frequency 0.803 1.018 0.887–1.167
Headache intensity 0.620 0.710 0.183–2.751
HADS-A 0.308 0.831 0.583–1.185
54 n.r. HADS-D 0.310 1–189 0.851–1.661
“Has a doctor ever given you a
diagnosis for this headache?” (Yes)
62 Age 0.111 1.041 0.991–1.095
Headache frequency 0.243 1.049 0.968–1.136
Headache intensity 0.133 2.117 0.795–5.632
HADS-A 0.423 1.089 0.884–1.342
18 n.r. HADS-D 0.289 0.902 0.746–1.091
“Because of your headaches, have
you had an MRI scan in the
last year?” (Yes)
14 Age 0.268 1.081 1.081–0.942
Headache frequency 0.948 1.007 1.007–0.824
Headache intensity 0.320 4.181 4.181–0.250
HADS-A 0.610 1.132 1.132–0.704
66 n.r. HADS-D 0.717 0.927 0.927–0.615
“Because of your headaches, have
you had a CT scan in the
last year?” (Yes)
14 Age 0.762 1.002 0.886- 1.180
Headache frequency 0.920 0.990 0.807–1.213
Headache intensity 0.620 0.414 0.013–13.525
HADS-A 0.327 1.302 0.768–2.207
66 n.r. HADS-D 0.544 0.869 0.552–1.368
“Because of your headaches, have
you had X rays of the neck in the
last year?” (Yes)
14 Age 0.996 50.502 0.000 -
Headache frequency 0.999 0.534 0.000 -
Headache intensity 0.997 2.735E+14 0.000 -
HADS-A 0.997 0.000 0.000 -
66 n.r. HADS-D 0.996 12683.366 0.000 –
* An odds ratio above one implies that higher age, headache frequency, headache intensity, scores in HADS-A or HADS-D increase the
likelihood of the answer given in brackets. An odds ratio smaller than 1 implies that younger age, lower headache frequency, scores in
HADS-A or HADS-D increase the likelihood of the answer given in brackets.
4. Discussion
This study investigated the influence of sex in patients with migraine or TTH on
different potential features influencing the burden of the disease. The key findings were
(1) marked sex-related differences among migraineurs, with women having a much higher
burden of disease, but (2) not among persons with TTH. In addition, (3) the headache
frequency emerged as the most crucial influence on the burden of migraine in women, but
not in men.
Our study revealed a high prevalence of stigmatization and social isolation, with 39%
avoiding telling others about their headache and 17% not feeling understood by family
and friends. In a previous study, Lampl et al. [19] found that only 10% of migraineurs did
not feel understood by family and friends. This discrepancy suggests cultural differences,
as Lampl et al. collected data from several European countries, whereas our sample solely
comprises participants from Switzerland.
Zebenholzer et al. [20] investigated factors influencing these aspects of the disease
burden. They found that depression increased the risk of avoiding telling others about
one’s headaches and increased the risk of feeling lonely and less understood by one’s
social environment. These findings fit well with the often-reported loneliness, lack of
social support and difficulties in relationships among patients with mental illnesses [21,22].
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Therefore, we find it surprising that our results do not confirm the significant influences of
depression or anxiety symptoms here.
At face value, a positive interaction with one’s social environment might be a helpful
coping strategy for many patients when experiencing illness or pain. However, headache
disorders are mainly characterized by recurring episodes of impairment that might force
the patient to interrupt their daily life for several hours or even days and thereby challenge
their relationships.
In line with previous studies [19], one third (35.51%) of our participants reported
having problems in their love lives due to their headaches, with women reporting more
problems than men. Our regression model revealed marked sex-related differences.
A higher headache frequency correlated with problems in participants’ love lives, not
feeling understood by their social surroundings, and a higher self-concealment in female
patients, but not in men. On the other hand, anxiety and depression symptoms, but not
headache frequency, influenced the appearance of problems in the love lives of men. The
explanation could be that the loss of time caused by the attacks led to relationship problems
in women, whereas the (interictal) affective state had a greater importance in men.
The reasons for women having a higher burden are far from well understood and
possibly lie in biology, social sciences, and psychology alike. In contrast to men, women are
more likely to seek support from others when ill [14], suggesting the differing interactions
with their social environment and the differing significance ratings of others’ support.
Considering that the need for support and fear of pain may affect the perceived social
support, women might be more likely to deplore its absence. Furthermore, typical gender-
related roles, responsibilities, and the distribution of tasks, with women taking care of
children and often “managing the daily family life” [23], might be more sensitive to time
loss due to a higher attack frequency.
About one third (30.41%) more women than men reported interictal anxiety. Slightly
fewer patients (29.76%) avoided “something” in order not to get headaches; here, the sex
ratios were balanced. Compared with previous studies, our participants experienced more
interictal anxiety, reported more avoidance and no sex-related differences in avoidance [19].
A higher pain intensity was related to a higher probability of interictal anxiety and avoid-
ance in women but not in men. However, in both sexes, a higher headache frequency had a
significant influence on interictal anxiety.
Inconsistent findings for sex-related differences for pain severity were described
before [10,24]. Here, in our sample, female migraineurs reported significantly higher pain
levels than men.
Previous studies showed a higher comorbidity burden and a bidirectional association
with depression, anxiety and migraine, as well as a higher frequency of psychiatric comor-
bidities in women [9,25]. In line with these findings, female migraineurs in our sample
scored higher in both HADS-D and HADS-A. The mean score for both sexes in HADS-D
was 7.11 ± 5.28 points, and the mean HADS-A was 8.51 ± 4.61 points. The diagnostic
limitations of the HADS did not allow a direct quantitative comparison with former results.
However, our results point in the same direction as those from the earlier literature. As
psychiatric comorbidities were likely to affect the burden of disease [9], we corrected the
regression model for the scores of HADS-A and HADS-D.
In summary, women experienced a more significant burden of disease, including
problems in relationships and their social interactions and love lives, interictal fear, a higher
pain intensity, and more depression and anxiety symptoms.
To shed light on the interaction of migraineurs within the healthcare systems, we
asked about consultations with primary physicians or headache specialists (neurologist).
Compared with earlier studies [26], we found more physician visits, possibly due to differ-
ent sampling strategies. In women, but not in men, a higher headache frequency correlated
with visits of a primary care physician or headache specialist. Interestingly, women re-
ceived a headache diagnosis from a doctor more often than men did, suggesting that men
were underdiagnosed with the “female attributed” disease. In line with our findings,
Brain Sci. 2021, 11, 1323 9 of 11
Scher et al. [24] showed that men were less likely than women to receive a migraine di-
agnosis, possibly due to different illness manifestations and the clinical characteristics of
the disease.
Men and women received medical imaging just as often as each other. However, in
women, a younger age and higher pain frequency was associated with a higher probability
of receiving an MRI scan of the brain. In addition, women with higher anxiety levels
received X-rays of the neck more often. Overall, our results indicated a mostly equal access
to healthcare and diagnostics for both sexes.
Prior studies revealed sex-related differences in tension-type headache, such as higher
levels of anxiety and depression in female patients than males [4,27]. In our study, we did
not find any significant difference. However, all samples were small and participants were
not compared with a control group. Besides, the burden might differ among geographic
regions. Thus, more comprehensive studies are required to address sex-related differences
in TTH. Nevertheless, our results do not suggest the need to invent or offer sex-specific
treatment options to address the disease burden of TTH.
It is observed that the interictal burden in migraine is higher than in TTH [19]. To our
knowledge, no previous, comprehensive study investigated the sex-related aspects that
influence the burden of disease.
5. Limitations
Some limitations need to be mentioned. First, our sample was not representative.
Despite a large number of participants, subgroups of the population might not have
participated. Second, the sample was not balanced as we included more cases of migraine
than TTH and, third, there were more female than male participants. Fourth, we assessed
the current headache frequency, while some other questions targeted other time periods.
Fifth, HADS was more suitable for screening than diagnosing depression and anxiety, with
a tendency to underestimate both [28]. Sixth, we did not correct for multiple testing as this
study was exploratory. Therefore, the risk of a Type 1 error might be increased. Seventh,
as our study included participants solely living in Switzerland, the results may not be
generalized to other countries.
6. Conclusions
Our results implied a greater need for sex-specific precision medicine for migraine
than for TTH, as we found several sex differences in the burden of disease of migraine but
not of TTH. Women experienced a higher burden of disease, especially in relationships and
social interactions. For migraine, the predominant factor which increased the burden of
disease in women was the headache frequency. Therefore, in everyday practice, sufficient
acute medication and prophylaxis were crucial to ease the burden of migraine on women.
Anxiety and depression symptoms in migraine were also more pronounced in women,
implicating the importance of psychotherapeutic or psychopharmacological treatment.
For male migraineurs, we did not find such evident influencing factors on the burden
of disease.
As biological, social, or behavioral factors may influence the disease burden, it may
be impossible to distinguish the relative importance of sex and gender. Nonetheless, it
is essential to consider that the disease burden comprises different aspects that require
different approaches in both men and women.
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